# Post-dengue transverse myelitis: a challenging case of neurological and therapeutic evidence

**Authors:** Bianca Frigo Pires, Caroline Goulart Nunes de Souza, Eduardo Coviello Mendes de Campos, Talles Rajab, Mariana Ferreira de Albuquerque, João Victor Padovani do Carmo, Fernanda Ferraioli de Paula, Luiz Guilherme Peleckis, Bruno Tolentino Foroni, Clara Luisa Negraes Navarrete, Fernanda Goulart Nunes de Souza, Gustavo Henrique de Moura Vardasca, Natalia Seno Croccia, Raiza Marques Vieira Campos, Ruy Yoshiaki Okaji

PMC · DOI: 10.1093/omcr/omag005 · Oxford Medical Case Reports · 2026-02-24

## TL;DR

A man developed spinal inflammation after dengue, showing how the virus can trigger neurological issues through immune reactions.

## Contribution

This case highlights post-dengue transverse myelitis as an immune-mediated complication with potential for recovery through early treatment.

## Key findings

- MRI showed spinal cord lesions consistent with transverse myelitis after dengue infection.
- Inflammatory CSF and positive dengue serology supported an immune-mediated cause.
- Treatment with steroids and rehabilitation led to neurological improvement.

## Abstract

Dengue is an arbovirus with significant global prevalence that can lead to severe neurological complications, such as longitudinally extensive transverse myelitis (LEMT).

We describe a 36-year-old man who developed sudden paraparesis and urinary retention approximately ten days after dengue infection. MRI revealed longitudinal hyperintense lesions in the cervical and thoracic spinal cord. Cerebrospinal fluid analysis revealed an inflammatory pattern and dengue serology was positive. The patient was treated with intravenous methylprednisolone and rehabilitation, leading to gradual neurological improvement and functional recovery.

Post-dengue transverse myelitis may result from parainfectious or post-infectious autoimmune mechanisms, often accompanied by demyelination and spinal cord inflammation. The low rate of DENV IgM in the CSF reinforces the immune-mediated hypothesis. Prognosis varies depending on the early intervention and the extent of spinal injury. Underreporting remains a challenge, and future studies should explore biomarkers and develop standardized management protocols.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741)
- **Diseases:** dengue (MONDO:0005502), transverse myelitis (MONDO:0021553)

## Full-text entities

- **Genes:** IVNS1ABP (influenza virus NS1A binding protein) [NCBI Gene 10625] {aka ARA3, FLARA3, HSPC068, IMD70, KLHL39, ND1}
- **Diseases:** autonomic dysfunction (MESH:D001342), vomiting (MESH:D014839), hyperreflexia (MESH:D012021), spinal cord compression (MESH:D013117), neurological deficit (MESH:D009461), fever (MESH:D005334), paraplegia (MESH:D010264), spinal cord injury (MESH:D013119), slowed (MESH:D012897), myelitis (MESH:D009187), nausea (MESH:D009325), Dengue (MESH:D003715), abdominal or retro-orbital pain (MESH:D015746), Hepatitis B and C (MESH:D006509), Neurological complications (MESH:D002493), calcifications (MESH:D002114), weakness (MESH:D018908), orbital pain (MESH:D010146), head trauma (MESH:D006259), alcoholism (MESH:D000437), inflammation (MESH:D007249), headache (MESH:D006261), Syphilis (MESH:D013587), loss of strength (MESH:D016388), neurological sequelae (MESH:D009422), motor and autonomic dysfunctions (MESH:D000068079), paraparesis (MESH:D020335), HIV (MESH:D015658), paresthesia (MESH:D010292), Tuberculosis (MESH:D014376), myalgia (MESH:D063806), petechiae (MESH:D011693), spinal injury (MESH:D013124), demyelination (MESH:D003711), LEMT (MESH:D009188), urinary and bowel retention (MESH:D016055), dysmetria (MESH:D002524)
- **Chemicals:** methylprednisolone (MESH:D008775), glucose (MESH:D005947), steroids (MESH:D013256), Rituximab (MESH:D000069283), STIR (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12931320/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12931320/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12931320/full.md

---
Source: https://tomesphere.com/paper/PMC12931320